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Abstract 
Apoptotic cells are quickly recognized and engulfed by phagocytes to prevent the release of 
noxious materials from dying cells. Phosphatidylserine (PS) exposed on the surface of 
apoptotic cells is a proposed „eat me‟ signal for the phagocytes. TMEM16F, a membrane 
protein with 8 transmembrane segments, has the Ca-dependent phospholipid scramblase 
activity. Here we show that when lymphoma cells were transformed with a constitutively 
active form of TMEM16F, they exposed a high level of PS that was comparable to that 
observed on apoptotic cells. The PS-exposing cells were morphologically normal, and grew 
normally. They efficiently responded to interleukin 3, and underwent apoptosis upon 
treatment with Fas ligand. The viable PS-exposing cells bound to peritoneal macrophages 
at 4°C, but not at 25°C. Accordingly, these cells were not engulfed by macrophages. When 





dendritic cells (DCs) in the spleen, but the PS-exposing living cells were not phagocytosed 
by these DCs. Furthermore, when PS-exposing lymphoma cells were transplanted s.c. into 
nude mice, they generated tumors as efficiently as parental lymphoma cells that did not 
expose PS. These results indicated that PS exposure alone is not sufficient to be recognized 
by macrophages as an “eat me” signal.  
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Introduction 
Many harmful and unnecessary cells are generated during animal development, and they 
undergo apoptosis (1). In adults, senescent cells and virus- or bacteria-infected cells are 
removed by apoptosis (2). Apoptotic cells are swiftly engulfed by macrophages or 
immature dendritic cells to prevent the release of noxious materials from the dying cells 
that may activate the immune system, leading to the autoimmune disease (3, 4).  
Macrophages specifically engulf apoptotic cells, but not living ones, indicating that the 
dying cells present an „eat me‟ signal(s) to the phagocytes. Phosphatidylserine (PS), which 
is present on the inner leaflet of plasma membranes in healthy cells, is quickly exposed to 
the outer plasma membrane of apoptotic cells, and has been proposed as an „eat me‟ signal 
(5). In fact, masking the PS on apoptotic cells inhibits their engulfment in vitro and in vivo 
(6, 7), strongly supporting the identification of PS as an „eat me‟ signal.  
The asymmetrical distribution of phospholipids on the plasma membrane is mediated 
by various transporters (8): ATP-dependent aminophospholipid translocase or flippase 
transports aminophospholipids from the outer leaflet to the cytoplasmic side. In addition, a 
Ca-dependent scramblase bidirectionally transports phospholipids. We recently identified 
TMEM16F (Transmembrane protein 16F), also called anoctamin 6, as this phospholipid 
scramblase (9). During that study, we noticed that an Asp-to-Gly point mutation at amino 
acid position 409 renders the molecule constitutively active; cells that express this mutant 
form of TMEM16F constitutively expose PS on their surface.  
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In this report, we found that there is an alternatively spliced variant of mouse 
TMEM16F. Mouse lymphoma cells expressing the TMEM16F splice variant with the 
Asp-to-Gly mutation exposed more PS than those expressing the authentic TMEM16F 
splice form with the same point mutation. These high-PS-exposing lymphoma cells grew 
normally, and responded normally to interleukin (IL) 3 by proliferating and to Fas ligand 
(FasL) by becoming apoptotic. The level of PS exposed on these cells was comparable to 
that observed on apoptotic cells. However, peritoneal macrophages did not engulf the 
viable PS-exposing cells, even though they efficiently engulfed apoptotic cells in a 
PS-dependent manner. When these living PS-exposing cells were transplanted into nude 
mice, they grew as aggressively as the parental lymphoma cells. These results indicate that 
although PS exposure is essential as an “eat me” signal, it is not sufficient for the apoptotic 
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Results 
PS exposure by TMEM16F mutants. We previously established a subline of Ba/F3 that 
strongly exposes PS in response to a Ca-ionophore (9). Expression cloning of the gene 
responsible for the PS exposure in this cell line identified a mutant TMEM16F that carried 
an Asp-to-Gly point mutation at codon 409 (D409G)(Fig. 1A). Further screening of the 
library led to the identification of the cDNA for a splice variant with the same point 
mutation generated by the insertion of an extra exon from intron 1 of the TMEM16F gene 
(Fig. 1B). The protein (D430G-long or D430G-L) which carried an extra peptide of 21 
amino acids at amino acid position 24 (Fig. 1C), showed scramblase activity that was 
apparently stronger than that of the D409G. As shown in Fig. 1D, introduction of the 
wild-type TMEM16F into Ba/F3 did not confer the cells to expose PS. When the D409G 
mutant was expressed in Ba/F3, about 70% of the cells constitutively exposed PS. On the 
other hand, Ba/F3 cells expressing D430G-L exposed PS more strongly than those 
expressing D409G, indicating that the 21-amino acid insertion in the first cytoplasmic 
region of mouse TMEM16F has a positive effect on its scramblase activity. A similarly 
high level of PS exposure was observed when D430G-L was expressed in mouse WR19 
cell transformants (W3-Ildm) expressing mouse Fas and the caspase-resistant form of 
ICAD (inhibitor of caspase-activated DNase) (10)(Fig. 1D).       
 
Effect of constitutive PS exposure on cell growth and apoptosis. The asymmetrical 
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distribution of phospholipids on the inner and outer plasma membrane is thought to be 
important for maintaining the integrity of plasma membranes (8). However, the 
Ba/F3-D430G-L cells, which constitutively exposed PS, grew as efficiently as the parental 
Ba/F3 cells; the doubling time of both Ba/F3 and Ba/F3-D430G-L cells in the presence of 
100 units/ml mouse IL-3 was 11.5 h (Fig. 2A). Accordingly, the dose-dependent response 
of the Ba/F3-D430G-L cells to IL-3 was comparable to that of the parental Ba/F3 cells (Fig. 
2B). The expression of the TMEM16F mutant or constitutive exposure of PS also had no 
effect on the growth of W3-Ildm cells (Fig. 2C). That is, the parental W3-Ildm and their 
D430G-L transformants grew at a comparable rate (doubling time of 12.5 h). The W3-Ildm 
cells over-express Fas, and are sensitive to FasL-induced apoptosis (10, 11). The 
dose-dependent response to recombinant FasL was comparable between W3-Ildm and its 
transformants expressing D430G-L (Fig. 2D). These results suggested that the constitutive 
exposure of PS had little effect on the binding of IL-3 or FasL to its respective receptor, and 
that the signal transduction induced by IL-3 to promote cell growth or by FasL to promote 
apoptosis occurs normally. 
 
Strong PS exposure on living cells. We then compared the level of PS exposed on the cell 
surface of the living W3-D430G-L cells with that on apoptotic cells. As shown in Fig. 3A, 
the Forward Scatter (FSC) and Side Scatter (SSC) profiles were similar between the 
W3-Ildm and W3-D430G-L cells. A small percentage of the W3-Ildm cells were 
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AnnexinV- and Sytox blue-positive, indicating that they underwent necrosis under normal 
growth conditions. Except for these necrotic cells, more than 90% of the W3-Ildm cells 
were Annexin V-negative. The W3-D430G-L cells also included a small percentage of 
necrotic cells, but nearly 95% of them were Annexin V-positive (Fig. 3A).  
When cells undergo apoptosis, their size decreases and cellular granularity increases 
(12). Accordingly, when the W3-Ildm and W3-D430G-L cells were treated with FasL for 2 
h, the FSC decreased from 118 to 68, and SSC increased from 66 to 127 in both cell lines 
(Fig. 3A), confirming that the constitutive PS exposure did not inhibit the FasL-induced 
apoptosis. The induction of apoptosis by FasL treatment caused PS to the cell surface of 
W3-Ildm without increasing the amount of Annexin V- and Sytox Blue-double positive 
necrotic cells. On the other hand, the treatment of W3-D430G-L with FasL did not increase 
the staining intensity of the Annexin V-binding, indicating that PS was exposed on the 
living W3-D430G-L cells to the same extent as on those undergoing apoptosis. MFG-E8 
specifically recognizes PS, independent of Ca (13), and it bound to the W3-D430G-L cells 
about as well as to the apoptotic W3-Ildm cells, indicating that both populations exposed 
PS at comparable levels (Fig. 3B).   
The PS exposure was then examined by confocal fluorescence microscopy. As shown 
in Fig. 3C, almost none of the living W3-Ildm cells were labeled much, if at all, by 
FITC-labeled MFG-E8. In contrast, the shrunken and rounded FasL-treated W3-Ildm cells 
uniformly bound MFG-E8. The lack of microvilli on the cell surface of the FasL-treated 
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cells confirmed that they had undergone apoptosis (14). The living non-apoptotic 
W3-D430G-L cells were also uniformly labeled with MFG-E8, but the cells were distorted, 
and their microvilli were visible (Fig. 3D). Treatment of the W3-D430G-L cells with FasL 
caused them to shrink and become rounded, accompanied by smoothing of the cell surface, 
but it did not enhance their ability to bind MFG-E8, confirming that the level of exposed PS 
did not differ between the living and apoptotic W3-D430G-L cells. 
 
No engulfment of the PS-exposing living cells by macrophages. Cells expressing the 
caspase-resistant form of ICAD do not undergo apoptotic DNA fragmentation (10). When 
these cells are engulfed by macrophages, DNase II in the lysosomes of the macrophages 
cleaves the DNA of the apoptotic cells. Using this system, we could distinguish the cells 
inside macrophages from those bound to the macrophage surface, to assay the engulfment 
of apoptotic cells (13). When FasL-treated W3-Ildm cells were co-incubated with 
thioglycollate-elicited peritoneal macrophages, 35-38% of the macrophages were stained 
with TUNEL (Fig. 4A). Microscopic observation of the macrophages confirmed that the 
apoptotic TUNEL-positive cells were inside the macrophages (Fig. 4B). The engulfment of 
the apoptotic W3-Ildm cells was PS-dependent, because it could be inhibited in a 
dose-dependent manner by the D89E mutant of MFG-E8 (Fig. 4C), which masks PS (13). 
On the other hand, like living W3-Ildm cells that did not expose PS, the PS-exposing living 
W3-D430G-L cells were not engulfed by the macrophages, although the cells could be 
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engulfed after they were treated with FasL (Fig. 4A and B).  
Mouse resident peritoneal macrophages express Tim-4, which specifically binds PS 
(15). To examine whether the PS exposed on W3-D430G-L cells was sufficient for the cells 
to bind macrophages, the cells were labeled with the cell-tracker CMRA, and incubated 
with macrophages. As shown in Fig. 4D and E, when the co-incubation was performed at 
4°C, the apoptotic W3-Ildm cells and the living W3-D430G-L cells, but not the living 
W3-Ildm cells, slowly bound to the macrophages. On the other hand, when the incubation 
temperature was increased to 25°C, the apoptotic W3-Ildm and apoptotic W3-D430G-L 
cells quickly bound to the macrophages, but the ability of the living W3-D430G-L cells to 
bind the macrophages was lost. These results suggested that the affinity of PS-exposing 
living W3-D430G-L cells for macrophages is weaker than that of apoptotic cells.       
 
No clearance of phosphatidylserine-exposing cells in vivo. Circulating apoptotic cells are 
engulfed in the spleen by CD8+CD11c+ dendritic cells (DCs) in a PS-dependent manner 
(16, 17). To investigate whether the viable PS-exposing cells could be engulfed by DCs, the 
CMRA-labeled viable or apoptotic W3-Ildm and W3-D430G-L cells were injected into 
syngeneic BALB/c mice. As shown in Fig. 5A, about 20% of the CD8+ DCs in the spleen 
carried apoptotic cells 30 min after the administration of dead cells. On the other hand, 
when the living W3-Ildm cells were injected, 6-8% of the CD8+ DCs were 
CMRA-positive, suggesting that some population of W3-Ildm cells underwent apoptosis in 
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vivo. The percentage of CMRA-positive CD8+ DCs obtained with the PS-exposing living 
W3-D430G-L cells was comparable to that obtained with the living W3-Ildm cells, 
indicating that the exposed PS was not sufficient for the viable cells to be engulfed by 
splenic CD8+ DCs.  
To confirm that the PS-exposing cells were not recognized by phagocytes in vivo, the 
W3-Idm and W3-D430G-L cells were injected into BALB/c nude mice. As shown in Fig. 
5B, both the W3-Ildm and W3-D430G-L cells generated tumors, which were of comparable 
size on day 28. Flow cytometry analysis of the recovered day 28-tumor cells revealed that a 
significant population (about 33%) of W3-D430G-L but not W3-Ildm cells constitutively 
exposed PS (Fig. 5C). The apparent reduction of the PS-exposing cells could be due to the 
poor environmental conditions (hypoxia and acidic conditions) for the tumor cells.    
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Discussion 
In this report, we found that the insertion of a 21-amino acid peptide at the N-terminal 
cytoplasmic region of TMEM16F strengthened the scramblase activity of its constitutively 
active mutant. Treating the cells with a Ca-chelator blocked the PS exposure caused by the 
mutant, suggesting that the mutant still required Ca for the scrambling activity. We used 
these high-PS-exposing cells to study the effects of cell-surface PS on cell growth and 
recognition by macrophages.   
We found that mouse lymphoma cells exposing a high level of PS could efficiently 
respond to cytokines, and grew normally in vitro and in vivo. In cells expressing the 
D409G mutant of TMEM16F, not only PS, but also phosphatidylethanolamine is exposed, 
and phosphatidylcholine and sphingomyelin are constitutively internalized (9), suggesting 
that the asymmetrical distribution of phopsholipids is largely disrupted in these cells. When 
IL-3 and FasL bind to their receptors, the resulting ligand/receptor complexes are 
internalized through the lipid raft/caveolar pathway for signal transduction (18, 19). Lipid 
rafts are heterogeneous domains of cell membranes that are rich in cholesterol, 
glycosphingolipids and phospholipids, and lipids play an essential role in maintaining the 
integrity of rafts (20). In this regard, it was very surprising to find that the PS-exposing 
cells responded to IL-3 and FasL as efficiently as the PS-non-exposing parental cells. It will 
be interesting to examine whether lipid rafts are present in the PS-exposing cells, and how 
the IL-3-IL-3-receptor complex and FasL-Fas complex are internalized for the signal 
  12 
transduction in these cells.  
PS is exposed during apoptotic cell death, and its exposure is necessary for the dead 
cells to be engulfed by macrophages (4, 21). PS is exposed in other situations, too. For 
example, activated platelets, mast cells, and neutrophils expose PS (22), while myocytes 
and trophoblasts transiently expose PS during their maturation (23, 24). Annexin 
V can bind to activated lymphocytes under some conditions (25-28), and to an ovarian 
carcinoma cell line (29), suggesting that these cells may also expose PS. Except for the 
activated neutrophils, these PS-exposing cells are not engulfed by macrophages. On the 
other hand, Fadok et al. reported that when the outer leaflets of living cells are enriched 
with PS by liposomes, the living cells are engulfed by macrophages (5). In contrast, we 
found that mouse lymphoma cells exposing PS were not engulfed if they were alive. This 
may agree with the previous report that the PS-exposure alone on apoptotic cells is 
insufficient to be recognized by human monocytes-derived macrophages (30). Borisenko et 
al (31) proposed that macrophages have a sensitivity threshold for the externalized PS for 
engulfment. However, the level of PS exposed on the surface of the viable W3-D430G-L 
was comparable to that observed on apoptotic cells, yet the former were not engulfed by 
macrophages, indicating that the PS level was not critical for determining whether the cells 
are engulfed or not.  
We found that the living PS-exposing cells bound to Tim-4-expressing resident 
peritoneal macrophages at 4°C, but not at 25°C, whereas the apoptotic cells quickly and 
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tightly bound the same macrophages at 25°C. These results suggest that PS exposed on the 
living cells is qualitatively different from the PS on apoptotic cells. Human Jurkat cells 
undergoing apoptosis expose oxidized PS (32), and MFG-E8, an opsonin for apoptotic cell 
engulfment, binds to oxidized PS with higher affinity than to non-oxidized PS (33). It will 
be interesting to examine whether or not the oxidization of PS exposed on viable cells 
allows them to be phagocytosed by macrophages.  
Other possible differences between viable and apoptotic PS-exposing cells are that 
viable cells present “don‟t eat me” signal(s) or apoptotic cells expose additional “eat me” 
signal(s) (3). Various molecules such as CD47, CD31, and PAI-1 (34-37) have been 
proposed as “don‟t eat me” signals. The PS-exposing W3-D430G-L cells do not express 
CD47, and antibodies against CD47 or its receptor SHPS-1 did not promote the engulfment 
of living W3-D430G-L cells by macrophages, indicating that CD47 is not responsible for 
preventing the engulfment, at least in this system. Regarding additional “eat me” signals, 
Gardai et al (38) reported that calreticulin is exposed on apoptotic cells, and promotes their 
engulfment. However, bovine calreticulin had no effect on the engulfment of W3-D430G-L 
cells by macrophages.  
In conclusion, we showed here that PS exposed on apoptotic cells is required but not 
sufficient for the dead cells to be engulfed. Another mechanism(s), a modification of PS, or 
additional molecules that could be “don‟t eat me” or “eat me” signal(s), must be involved 
for the efficient engulfment of apoptotic cells. The cell line established in this report, which 
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strongly exposes PS while remaining viable, will be useful for elucidating how 
macrophages recognize apoptotic cells for engulfment.  
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Materials and Methods 
Mice, cell lines, recombinant proteins, and reagents. C57BL/6J, BALB/c, and BALB/c 
nude mice were purchased from Clea Japan. All mouse studies were approved by the Ethics 
Review Committee for Animal Experimentation of the Graduate School of Medicine, 
Kyoto University. Mouse IL-3-dependent Ba/F3 cells were maintained in RPMI medium 
containing 10% fetal calf serum (FCS; Gibco), 100 U/ml mouse IL-3 and 50 μM 
2-mercaptoethanol. W3-Ildm is a transformant of mouse T-cell lymphoma (WR19L) that 
expresses mouse Fas and a caspase-resistant form of the inhibitor of caspase-activated 
DNase (ICAD) (10), and was cultured in DMEM containing 10% FCS. Mouse IL-3 was 
produced by mouse C127I cells transformed with a bovine papillomavirus expression 
vector bearing IL-3 cDNA as described (39). The biological activity of the mouse IL-3 was 
determined with Ba/F3 cells, and one unit is defined as the dilution that gives a 
half-maximum response. The recombinant soluble form of human Fas ligand (FasL) and 
the D89E mutant of mouse MFG-E8 were produced in COS7 and HEK293T cells 
respectively, and purified as described (13, 40). The biological activity of FasL was 
determined with W3-Ildm cells, and one unit is defined as that dilution that gives a 
half-maximum response. The FITC-labeled bovine MFG-E8 (BLAC-FITC) was from 
Hematologic Technologies. CellTracker
TM
 Orange CMRA was from Invitrogen. Rat mAbs 
against mouse Mac-1 (clone M1/70), FcRII/III (clone 2.4G2), CD11c (clone HL3), Thy1.2 
(clone 53-2.1), and CD8clone 53-6.7) were purchased from BD Pharmingen.  
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Transformation of mouse Ba/F3 and W3-Ildm cells. Ba/F3 and W3-Ildm cells were 
subjected to ecotropic and amphotropic retrovirus-mediated transformation, respectively. In 
brief, the retrovirus carrying the Flag-tagged TMEM16F cDNA was produced by 
introducing the pMX-puro vector into Plat-E cells expressing MuLV gag-pol and env 
(41), or into 293T cells with the amphotrophic retrovirus-packaging construct pE-Ampho 
(Takara Bio). The retroviruses were concentrated by centrifugation at 6,000 x g for 16 h at 
4ºC, and used to infect Ba/F3 and W3-Ildm cells. The transformants were selected by 
culturing the cells in the presence of 1 g/ml puromycin. If necessary, a population (1-5%) 
of the transformants that was strongly stained with Annexin V was sorted by FACSAria 
(BD Bioscience) for further studies.  
 
Induction of apoptosis, and detection of phosphatidylserine. To induce apoptosis, cells 
(1.0 x 10
6
 cell/ml) were incubated with 100 U/ml FasL at 37°C for 2 h. The cell viability 
was assayed by WST-1 assay with 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5- 
(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-1; Dojin 
Laboratories) and 1-Methoxy-5-methylphenazinium methylsulfate as described 
(11). To detect PS, cells were stained at 25°C for 5 min with 1,000-2,000-fold diluted 
Cy5-labeled Annexin V (Biovision) or 800 ng/ml FITC-MFG-E8 in staining buffer [10 mM 
Hepes-KOH (pH 7.4) containing 140 mM NaCl and 2.5 mM CaCl2], followed by 
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incubation with 500 nM SYTOX Blue, and analyzed by FACSAria. For microscopic 
observation, 2 × 10
5 
cells in 8-well Lab-Tek II chamber slides (Nalge Nunc) were incubated 
on ice for 15 min with 4 g/ml FITC-MFG-E8 in staining buffer, and observed by 
fluorescence microscopy (FV1000-D, Olympus).     
 
Preparation of macrophages, and in vitro phagocytosis assay. Resident peritoneal 
macrophages were prepared from of 6-12-week old C57BL/6J mice as described (15). To 
prepare thiogycollate-elicited peritoneal macrophages, the mice were injected with 60 mg 
of thioglycollate, and the peritoneal macrophages were collected 4 days later. The in vitro 
phagocytosis assay was performed as described previously (13, 42). In brief, 6 × 105 
thioglycollate-elicited peritoneal macrophages were grown overnight in 12-well cell culture 
plates (Corning). Apoptotic or PS-exposing cells (3 ×10
6
) were added to the macrophages, 
and the mixture was incubated at 37ºC for 2 h in the presence of 1 g/ml rat anti-mouse 
FcRII/III. Macrophages were detached from the plate by treatment with 0.25% trypsin in 
PBS containing 1 mM EDTA, and stained with APC-conjugated rat anti-mouse Mac-1, 
followed by TUNEL staining with FITC-labeled dUTP (Roche Molecular Biochemicals). 
Flow cytometry was conducted using a FACSAria, and the percentage of phagocytosis was 
defined as the percentage of TUNEL-positive cells in the Mac-1-positive population. In 
some cases, peritoneal macrophages (6 × 10
4 
cells) were incubated with living or apoptotic 
cells (3 × 10
5 
cells/well) in 8-well Lab-Tek II chambers. After fixation with 1% 
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paraformaldehyde, the cells were subjected to TUNEL staining using the Apoptag kit 
(Millipore), and observed by fluorescence microscopy.  
 
Binding of PS-exposing cells to macrophages. CMRA-labeled living or apoptotic cells 
(2.5-5  105 cells) were co-incubated in suspension with freshly prepared peritoneal cells (1 
 105 cells) in PBS supplemented with 10% FCS. The cells were stained with 
APC-conjugated anti-Mac-1, followed by 500 nM SYTOX Blue, and analyzed by 
FACSAria. For microscopic observation, 1  105 peritoneal cells were seeded into 8 -well 
Lab-Tek II chambers, incubated at 37ºC for 2 h, and washed with PBS containing 10% FCS. 
CMRA-labeled cells (5  105 cells) were added to the well, and the mixture was incubated 
on ice for 1 h. After the incubation, cells were washed three times with pre-chilled PBS, 
stained with Alexa fluor 488-conjugated anti-Mac-1 for 5 min on ice, and observed by 
fluorescence microscopy (BioRevo BZ-9000, Keyence).  
 
In vivo phagocytosis assay, and tumor development. The in vivo phagocytosis assay was 
carried out as described (17). In brief, 5 × 10
7
 W3-Ildm living cells were pre-incubated for 
60 min with a caspase inhibitor, 10 M Q-VD-OPh (R&D systems), and stained at 25°C for 
30 min with 4 M 5-(((4-chloromethyl)benzoyl)amino) tetramethylrhodamine (CMRA) 
(Invitrogen). Apoptosis was induced by treating the cells with 100 U/ml FasL for 90 min at 
37ºC. Then, 3 × 10
7
 CMRA-labeled cells in 300 l of PBS were injected i.v. into 
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8-weeks-old female BALB/c mice. Thirty minutes later, the spleens were dissected, flushed 
with 100 U/ml collagenase D (Roche Diagnosis), teased apart with fine forceps, and 
digested with 400 U/ml collagenase D for 30 min at 37ºC. After hemolysis with EL buffer 
(Qiagen), the DCs were enriched by MACS sorting with anti-mouse CD11c microbeads 
(Miltenyi Biotec). They were then stained with APC- rat anti-mouse CD11c and FITC- rat 
anti-mouse CD8, followed by staining with 500 nM SYTOX Blue, and analyzed by 
FACSAria. In some cases, the CMRA-positive cells in the CD11c
+
CD8+ population were 
sorted by FACSAria, and observed by fluorescence microscopy. 
To examine the ability of lymphoma to grow in vivo, cells (1 x 10
6
) were injected  
into 8-week-old female BALB/c nude mice. Four weeks later, the tumors were dissected, 
and their weight was determined. The dissected tumors were further teased apart with fine 
forceps, and digested with collagenase D as described above. After passing through mesh, 
the cells were washed with cold PBS, and stained with Cy5-labeled Annexin V, followed by 
staining with 1 g/ml FITC-rat anti- mouse Thy1.2 and SYTOX Blue, and analyzed by 
FACSAria. 
 
Statistical analysis. All data were expressed as the mean with SD. Differences between 
groups were examined for statistical significance using the Student‟s t-test with the 
Bonferroni correction.  
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Legends to Figures  
Fig. 1. Constitutive exposure of phosphatidylserine on TMEM16F mutants. (A) Schematic 
diagrams of mouse TMEM16F (wild-type) and its mutants D409G and D430G-L. The 
wild-type mouse TMEM16F is comprised of 911 amino acids. The D409 mutant carries a 
glycine residue in place of an aspartic acid at codon 409. In the D430G-L mutant, a 
21-amino acid peptide is inserted at amino acid position 24. (B) A splice variant produces 
TMEM16F carrying an extra peptide. A population of TMEM16F mRNA uses a sequence 
in intron 1 as an extra exon that codes for 21 amino acids. (C) Schematic representation of 
TMEM16F mutants. The Asp-to-Gly point mutation is in the first cytoplasmic loop, while 
the 21-amino acid insertion is in the N-terminal cytoplasmic domain. (D) Left four panels, 
Ba/F3 cells were transformed with the empty vector, wild-type TMEM16F, its D409G 
mutant, or its D430G-L mutant. The amount of PS exposed on the cells was analyzed by 
Cy5-labeled Annexin V, followed by FACS analysis. In the right panel, W3-Ildm cells 
were transformed with D430G-L, and the PS exposure was analyzed as above.      
 
Fig. 2. No effect of phosphatidylserine exposure on cell growth or cytokine responses. (A) 
Mouse Ba/F3 and Ba/F3-D430G-L cells were seeded at 10
4
 cells/ml in 1 ml of RPMI1640 
medium containing 10% FCS and 100 units/ml mouse IL-3, and cultured at 37°C for 6 days. 
The cells were split 1:100 every 3 days, and their growth was followed. (B) Ba/F3 and 
Ba/F3-D430G-L cells were washed with RPMI1640 containing 10% FCS, and cultured at 
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37°C for 48 h in medium containing the indicated concentration of mouse IL-3. The cell 
viability was then determined by the WST-1 assay, and is expressed as the percentage of 
that obtained with 64 units/ml IL-3. (C) Mouse W3-Ildm and W3-D430G-L cells were 
seeded at 3 x 10
4
 cells/ml in 1 ml of RPMI1640 medium containing 10% FCS, and cultured 
at 37°C for 9 days. The cells were split 1:80 every 3 days, and the cell growth was followed. 
(D) W3-Ildm and W3-D430G-L cells were incubated at 37°C for 4 h with the indicated 
concentration of human FasL. The cell viability was then determined by the WST-1 assay, 
and is expressed as the percentage of that without FasL.     
 
Fig. 3. Exposure of phosphatidylserine on living W3-D430G-L cells. (A) W3-Ildm and 
W3-D430G-L cells with or without FasL treatment were stained with Cy5-labeled Annexin 
V and SytoxBlue, and analyzed by flow cytometry. The left 4 panels show the FSC-SSC 
profile, while the right 4 panels show the profile for Annexin V-SytoxBlue staining. (B) 
W3-Ildm and W3-D430G-L cells with or without FasL treatment were stained with the 
FITC-labeled MFG-E8, and analyzed by FACS. The MFG-E8 staining profile in the Sytox 
Blue-negative population is shown. (C and D) W3-Ildm and W3-D430G-L cells with or 
without FasL treatment were stained with FITC-labeled MFG-E8, and observed by 
confocal fluorescence microscopy. Images for MFG-E8 (green) and differential 
interference contrast (DIC) are shown. Arrowheads indicate microvilli. Scale bar, 10 m.       
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Fig. 4. No engulfment of the PS-exposing living cells by macrophages. (A) TUNEL 
staining profile of Mac-1
+
 thioglycollate-elicited peritoneal macrophages. W3-Ildm and 
W3-D430G-L cells that had been untreated or treated with FasL were co-incubated for 2 h, 
subjected to TUNEL-staining, and analyzed by FACS. The TUNEL staining profile of the 
Mac-1
+
 population is shown. The number indicates the percentage of TUNEL-positive cells. 
(B) W3-Ildm and W3-D430G-L cells that had been untreated or treated with FasL were 
co-incubated for 2 h with thioglycollate-elicited peritoneal macrophages, stained for 
TUNEL and DAPI, and observed by confocal microscopy. Images for TUNEL (green) and 
merged images for TUNEL, DAPI, and DIC are shown. Scale bar, 10 m. (C) W3-Ildm 
cells were treated with FasL, incubated at 25°C for 5 min with the indicated concentrations 
of the D89E mutant of mouse MFG-E8, and co-incubated for 2 h with 
thioglycollate-elicited peritoneal macrophages. The macrophages were then subjected to 
TUNEL staining, followed by flow cytometry. The phagocytosis index indicates the 
percentage of TUNEL-positive macrophages. (D) Binding of the PS-exposing cells to 
macrophages. Untreated or FasL-treated CMRA-labeled W3-Ildm and W3-D430G-L cells 
(5 x 10
5
 cells for 4°C, and 2.5 x 10
5
 cells for 25°C incubation) were incubated at 4°C or 
25°C for the indicated period with resident peritoneal cells (1 x 10
5
 cells). The cells were 
stained with APC-labeled anti-Mac-1, and analyzed by flow cytometry. The percentage of 
CMRA-positive macrophages in the Mac-1
+
 population is plotted. In left panels, 
representative FACS profiles in which the FasL-treated W3-Ildm cells were incubated at 
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25°C for 0 or 60 min are shown. (E) The CMRA-labeled W3-ldm and W3-D430G-L (red) 
cells, with or without FasL-treatment, were incubated at 4°C for 60 min with resident 
peritoneal cells. They were thoroughly washed with cold PBS, stained with Alexa Fluor 
488-anti-Mac1 (green), and observed by fluorescence microscopy. Arrows indicate 
macrophages surrounded by CMRA-labeled cells. Scale bar, 20 m.     
 
Fig. 5. No clearance of the viable PS-exposing cells in vivo. (A) CMRA-labeled W3-Ildm 
and W3-D430G-L and FasL-treated W3-Ildm cells were injected into syngeneic female 
BALB/c mice. Thirty minutes after the injection, the splenic DCs were enriched by MACS 
sorting and analyzed by flow cytometry. The CMRA profile of the CD11c
+
CD8+ 
population is shown. The Number indicates the percentage of CMRA-positive cells in the 
CD11c
+
CD8+ population. Average values of 3-4 mice/group are shown with S.D. *P < 
0.01. (B) Tumor development. W3-Ildm and W3-D430G-L cells (1.0 x 10
6
 cells) were 
transplanted s.c. into 5 BALB/c nude mice, respectively. Four weeks later, the tumors were 
dissected and their weight was determined. Left panel, a picture of mice with tumors of the 
indicated cell line. Right panel, weights of tumors. The average values of the tumors from 5 
mice are indicated by red horizontal bars. (C) PS-exposure in the tumors developed in nude 
mice. Annexin V-staining profile of the Thy1.2
+
 tumor cells of the indicated cell line is 
shown. The number indicates the percentage of Annexin V-positive cells. 
 





